Developing Solid Oral Dosage Forms

Developing Solid Oral Dosage Forms, 1st Edition

Pharmaceutical Theory and Practice

Developing Solid Oral Dosage Forms, 1st Edition,Yihong Qiu,Yisheng Chen,Geoff Zhang,Lirong Liu,William Porter,ISBN9780444532428

Qiu   &   Chen   &   Zhang   &   Liu   &   Porter   

Academic Press

9780444532428 New edition



276 X 216

This book is intended for pharmaceutical professionals engaged in research and development of oral dosage forms and covers essential principles of physical pharmacy, biopharmaceutics and industrial pharmacy as well as various aspects of state-of-the-art techniques and approaches in pharmaceutical sciences and technologies along with examples and/or case studies in product development.

Print Book + eBook

USD 318.00
USD 530.00

Buy both together and save 40%

Print Book


In Stock

Estimated Delivery Time
USD 270.00

eBook Overview

VST (VitalSource Bookshelf) format

DRM-free included formats : EPUB, Mobi (for Kindle), PDF

USD 260.00
Add to Cart

Key Features

The first book (ever) that provides comprehensive and in-depth coverage of what's required for developing high quality pharmaceutical products to meet international standards

It covers a broad scope of topics that encompass the entire spectrum of solid dosage form development for the global market, including the most updated science and technologies, practice, applications, regulation, intellectual property protection and new development trends with case studies in every chapter

A strong team of more than 50 well-established authors/co-authors of diverse background, knowledge, skills and experience from industry, academia and regulatory agencies


This book is intended for pharmaceutical professionals engaged in research and development of oral dosage forms. It covers essential principles of physical pharmacy, biopharmaceutics and industrial pharmacy as well as various aspects of state-of-the-art techniques and approaches in pharmaceutical sciences and technologies along with examples and/or case studies in product development. The objective of this book is to offer updated (or current) knowledge and skills required for rational oral product design and development. The specific goals are to provide readers with:

Basics of modern theories of physical pharmacy, biopharmaceutics and industrial pharmacy and their applications throughout the entire process of research and development of oral dosage forms

Tools and approaches of preformulation investigation, formulation/process design, characterization and scale-up in pharmaceutical sciences and technologies

New developments, challenges, trends, opportunities, intellectual property issues and regulations in solid product development


PRIMARY MARKET: Pharmaceutical researchers at both pharmaceutical companies & academic institutions focused on developing solid dosage forms fpr drug delivery.

SECONDARY MARKET: Advanced graduate level courses in the pharmaceutical sciences programs in the US and EMEA.

Yihong Qiu

Dr. Yihong Qiu is currently a Senior Research Fellow, Oral Drug Products, Science and Technology, AbbVie. His in-depth knowledge and extensive experience encompass various phases of product development, including preformulation, drug delivery technology, product/process design, biopharmaceutics/pharmacokinetics, formulation/process development, scale-up and optimization, manufacturing trouble-shooting, intellectual property and regulatory registration for NCE’s, line-extension and marketed products. He also plays a key role in the product life cycle management, IP strategy, scientific and regulatory assessment of business opportunities. During his 25-year tenure with Abbott/AbbVie, his work has resulted in successful commercial IR and MR products, patented drug delivery technologies, IVIVC’s and biowaivers approved by global regulatory agencies. Dr. Qiu’s research interests include modified-release delivery systems, dissolution, bioavailability, IVIVC, drug delivery technology and science-based regulation. He is an elected fellow of the American Association of Pharmaceutical Scientists (AAPS), a member of 2010-2015 USP Expert Committee and a review committee member of Chang Jiang Scholars Program (2014-15). He has more than 50 publications in journals and books, 30 patents granted or pending, and numerous invited presentations. He is routinely invited to lecture at professional organizations and universities. Dr. Qiu received BS in Pharmacy, MS. in Pharmaceutics from China Pharmaceutical University, and Ph.D. in Pharmaceutics from The University of Iowa.

Affiliations and Expertise

PhD, Senior Research Fellow, Oral Drug Products, Manufacturing Science and Technology, AbbVie Inc., North Chicago, IL, USA

Yisheng Chen

Dr. Yisheng Chen currently serves as Vice President of Product Development at Novast Laboratories, Ltd, leading the development of pharmaceutical products for global markets. Dr. Chen earned his Ph.D. degree in Pharmaceutics in 1994 from the University of Iowa. He then joined Burroughs Wellcome as a development scientist, and later Abbott Laboratories with increasing responsibilities where he was elected as an Associate Research Fellow, Volwiler Society. Dr. Chen also served as an expert member of both the Product Quality Research Institute (PQRI) and the USP Performance Testing Expert Panel, and as an adjunct professor at the Guangdong Pharmaceutical University. Dr. Chen has in-depth knowledge and extensive experience in various aspects of developing solid pharmaceutical products, ranging from formulation and process development, CMC documentation for regulatory filing, scale-up, and validation for commercialization. His expertise includes the quality by design (QbD) development of modified release (MR) products using traditional delivery technologies, and development of new delivery systems for MR products. Dr. Chen has extensive experience in the development and scale-up of beads coating process using Wurster coating technology for different types of products from lab to commercial scales. He has successfully led the development and secured the approval of more than 30 products approved in the US, EU, Japan and China, including new drug applications (NDAs) and high barrier branded abbreviated new drug applications (ANDAs). Dr. Chen also has the expertise in packaging protection of drug products. He developed a theoretical model for predicting moisture uptake by packaged products during storage. His theory provided the fundamental basis for the development of ASTM D7709 and the revision of USP general chapter <671> on the standard methods for measuring the water vapor transmission rate (WVTR) of containers, as well as the scientific criteria of using MVTR/unit product to evaluate the performance of containers for product protection. Dr. Chen has published over 30 peer-reviewed articles, book chapters, and patents. He is a co-editor of “Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice”. Dr. Chen is a frequent speaker at national and international conferences, and at major universities.

Affiliations and Expertise

Vice President, Novast Laboratories, Nantong, China

Geoff Zhang

Dr. Geoff G. Z. Zhang is a Senior Research Follow at AbbVie Inc., an adjunct professor of the Department of Industrial and Physical Pharmacy at Purdue University, and a Fellow of the American Association of Pharmaceutical Scientists. He received his B.Sc. in Physical Chemistry from Fudan University, China, and Ph.D. in Pharmaceutics from the University of Minnesota, USA. He has contributed broadly to Physical Pharmacy, specifically in the areas of crystal engineering, polymorphism, characterization and crystallization of amorphous solids and amorphous solid dispersions, as well as delivery of poorly water soluble compounds. He has published over 70 peer-reviewed articles, reviews, and book chapters, given over 170 podium and poster presentations. During his 18-year tenure with Abbott/AbbVie, he has more than 120 granted patents and patent applications. He interacts and collaborates extensively with academic institutes and has mentored 40 graduate students on their thesis and summer research projects. He has received 2012 AAPS Pharmaceutical Research Meritorious Manuscript Award, and serves on the United State Pharmacopeia Physical Analysis Expert Committee.

Affiliations and Expertise

Senior Research Fellow, Drug Product Development, Abbvie, Inc., North Chicago, IL, USA

Lirong Liu

Affiliations and Expertise

Pfizer Inc., NJ, USA

William Porter

Affiliations and Expertise

Abbott Laboratories, IL, USA

Developing Solid Oral Dosage Forms, 1st Edition

Ch 1 Solubility of Pharmaceutical Solids
Ch 2 Crystalline and Amorphous Solids
Ch 3 Analytical Techniques in Solid State Characterization
Ch 4 Salt Screening and Selection: New Challenges and Considerations in the Modern Pharmaceutical R&D Paradigm
Ch 5 Drug Stability and Stability Studies
Ch 6 Excipient Compatibility
Ch 7 Theory of Diffusion and Pharmaceutical Applications
Ch 8 Particle, Powder and Compact Characterization
Ch 9 Polymer Properties and Characterization
Ch 10 Applied Statistics in Product Development
Ch 11 Oral Absorption Basics: Pathways, Physicochemical and Biological Factors, and Methods of Study
Ch 12 Oral Absorption Evaluation and Prediction
Ch 13 Fundamentals of Dissolution
Ch 14 Dissolution Testing of Solid Products
Ch 15 Bioavailability and Bioequivalence
Ch 16 In Vivo Evaluation of Dosage Form Performance
Ch 17 In Vitro-In Vivo Correlations: Fundamentals, Applications and Development Considerations
Ch 18 Integration of physical, chemical, mechanical and biopharmaceutical properties in solid oral dosage form development
Ch 19 Design and Development of Self-Emulsifying Drug Delivery Systems for Enhanced Oral Absorption of Poorly Soluble Compounds
Ch 20 Rational Design of Oral Modified-Release Drug Delivery Systems
Ch 21 Development of Modified-Releas Oral Dosage Forms
Ch 22 Analytical Development and Validation for Solid Oral Dosage Forms
Ch 23 Statistical Design and Analysis of Long Term Stabilty Studies for Drug Products
Ch 24 Packaging selection for solid dosage forms
Ch 25 Clincial Supplies Manufacture
Ch 26 Specification Setting and Manufacturing Process Control for Solid Oral Drug Products
Ch 27 Scale-Up Of Pharmaceutical Manufacturing Operation of Solid Dosage Forms
Ch 28 Process Development, Optimization and Scale-Up: Powder Handling and Segregation Concerns
Ch 29 Process Development and Scale-Up of Wet Granulation by High-Shear Process
Ch 30 Development,Scale-Up and Optimization of Fluid-bed Granulation
Ch 31 Development, Optimization and Scale-Up of Process Parameters: Roller Compaction
Ch 32 Development, Optimization And Scale-Up Of Process Parameters: Compression
Ch 33 Development, Optimization & Scale-Up of Process Parameters: Pan Coating
Ch 34 Development, Optimization And Scale-Up Of Process Parameters: Wurster Coating
Ch 35 Process Analytical Technology
Ch 36 The Product Development Process
Ch 37 Product Registration and Drug Approval Process
Ch 38 Modern Pharmaceutical Development Regulations
Ch 39 Intellectual Property in Pharmaceutical Development
Ch 40 Product Life-Cycle Management
Free Shipping
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy

Contact Us